Alimera Sciences reported $20.6M in Market Capitalization this February of 2023, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Abbvie ABBV:US USD 237.3B 33.36B
Alimera Sciences ALIM:US USD 36M 2M
Bayer BAYN:GR EUR 46.58B 9.14B
Insmed INSM:US USD 2.62B 258M
Novartis NOVN:VX USD 181.55B 12.79B
Ophthotech OPHT:US USD 2.12B 998M
Regeneron Pharmaceuticals REGN:US USD 78.57B 3.48B
Roche Holding ROG:VX CHF 263.11B 68.64B